menu
    • menu

    Company profile for ProQR Therapeutics

    NEW Drugs in Dev: 7
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are ProQR, a company on a mission to create new medicines for patients in need. We focus on a group of diseases called rare diseases, with a very high need for new medicines. Out of the approximately 7,000 rare diseases, less than 400 have a treatment, and we intend to change that. To treat these diseases we use RNA therapies, a technology that allows us to address inherited diseases that are caused by a genetic defect.Our ...
    We are ProQR, a company on a mission to create new medicines for patients in need. We focus on a group of diseases called rare diseases, with a very high need for new medicines. Out of the approximately 7,000 rare diseases, less than 400 have a treatment, and we intend to change that. To treat these diseases we use RNA therapies, a technology that allows us to address inherited diseases that are caused by a genetic defect.Our focus is on diseases that are very severe and have limited treatment options.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ProQR TherapeuticsNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Zernikedreef 9 Leiden, Zuid-Holland 2333CK, NL
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.proqr.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/proqr-therapeutics-bv/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/proqr

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ProQR Announces Year End 2025 Operating And Financial Results
    ProQR Announces Year End 2025 Operating And Financial Results

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254449/33039/en/ProQR-Announces-Year-End-2025-Operating-and-Financial-Results.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Proqr To Webcast Presentation At 2026 Citizens Life Sciences Conf
    Proqr To Webcast Presentation At 2026 Citizens Life Sciences Conf

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248959/33039/en/ProQR-Announces-Webcast-of-Presentation-at-the-2026-Citizens-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Proqr Announces Planned Changes To Board Composition
    Proqr Announces Planned Changes To Board Composition

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234489/33039/en/ProQR-Announces-Planned-Changes-to-Board-Composition.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    ProQR Announces AX-0810 Phase 1 Data and 2026 Candidate
    ProQR Announces AX-0810 Phase 1 Data and 2026 Candidate

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215343/33039/en/ProQR-Announces-Encouraging-AX-0810-Phase-1-Safety-and-PK-Data-Development-Candidate-Selections-and-2026-Outlook.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Proqr To Participate In 8Th Annual Evercore Healthcare Conference
    Proqr To Participate In 8Th Annual Evercore Healthcare Conference

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196934/33039/en/ProQR-to-Participate-in-8th-Annual-Evercore-Healthcare-Conference.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Proqr Gets CTA For AX-0810 Plans Investor Event Nov 3, 2025
    Proqr Gets CTA For AX-0810 Plans Investor Event Nov 3, 2025

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169294/33039/en/ProQR-Receives-CTA-Authorization-for-AX-0810-and-Announces-Virtual-Investor-and-Analyst-Event-on-November-3-2025.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search